60
Participants
Start Date
July 28, 2022
Primary Completion Date
July 30, 2024
Study Completion Date
November 30, 2024
ClearSight
The primary hypothesis is that continuous non-invasive monitoring using ClearSight reduces the incidence of intraoperative hypotensive events (defined by mean arterial pressure below a value of 65 mmHg for more than 1 minute) and the duration of the events themselves, leading to an improvement in patients' outcomes.
Policlinico A. Gemelli, Rome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER